FDA has accepted and granted Priority Review to the biologics license application for ifinatamab deruxtecan in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results